Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

Chatterjee, Pratishtha; Pedrini, Steve; D. Doecke, James; Thota, Rohith; L. Villemagne, Victor; Doré, Vincent; K. Singh, Abhay; Wang, Penghao; Rainey‐Smith, Stephanie; Fowler, Christopher; Taddei, Kevin; R. Sohrabi, Hamid; P. Molloy, Mark; Ames, David; Maruff, Paul; C. Rowe, Christopher; L. Masters, Colin; N. Martins, Ralph; AIBL Research Group, the

doi:10.1002/alz.12724

Public

Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

Shared by NobleBlocks on Jul 21, 2022 • 12:00 AM UTC

Authors:

Pratishtha Chatterjee

Steve Pedrini

James D. Doecke

Abstract

Abstract Introduction Plasma amyloid beta (Aβ)1‐42/Aβ1‐40 ratio, phosphorylated‐tau181 (p‐tau181), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL) are putative blood biomarkers for Alzheimer's disease (AD). However, head‐to‐head cross‐sectional and longitudinal comparisons of t...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!